The payoff for understanding Chlamydia trachomatis immunology is the development of a
vaccine. Two lines of research have contributed to our current understanding of C …

Sexually transmitted Chlamydia trachomatis infections are a serious public-health problem.
With more than 90 million new cases occurring annually, C. trachomatis is the most common …

Chlamydia trachomatis is a prevalent pathogen in human populations in both developing
and developed areas of the globe. Disease burden is heavy, since both acute and chronic …

In this issue of the Journal, Geisler and colleagues [1] report convincing epidemiological
evidence that cervical infection with Chlamydia trachomatis produces immunity in at least a …

Members of the genus, Chlamydia, are obligate intracellular bacteria that have a unique
developmental cycle. These organisms are widespread in nature and are common human …

Chlamydia trachomatis is the causative agent of a highly prevalent sexually transmitted
bacterial disease and is associated with a number of severe disease complications. Current …

Chlamydia trachomatis is an obligate intracellular bacteria characterized by a biphasic
development cycle of replication. The organism is now recognized the major cause of …

Chlamydia muridarum and Chlamydia trachomatis mouse models of genital infection have
been used to study chlamydial immunity and vaccine development. To assess the protective …

This review examines the immunity, immunopathology, and contemporary problems of
vaccine development against sexually transmitted Chlamydia trachomatis. Despite improved …

Chlamydia trachomatis is an obligate intracellular bacterial pathogen that causes several
significant human infectious diseases, including trachoma, urethritis, cervicitis and …